Detalhe da pesquisa
1.
Bladder Cancer, Version 3.2024.
J Natl Compr Canc Netw
; 22(4): 216-225, 2024 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38754471
2.
BTK inhibition potentiates anti-PD-L1 treatment in murine melanoma: potential role for MDSC modulation in immunotherapy.
Cancer Immunol Immunother
; 72(11): 3461-3474, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37528320
3.
Oncologic outcomes among Black and White men with grade group 4 or 5 (Gleason score 8-10) prostate cancer treated primarily by radical prostatectomy.
Cancer
; 127(9): 1425-1431, 2021 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33721334
4.
Downgrading from Biopsy Grade Group 4 Prostate Cancer in Patients Undergoing Radical Prostatectomy for High or Very High Risk Prostate Cancer.
J Urol
; 204(4): 748-753, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32259468
5.
Outcomes of very high-risk prostate cancer after radical prostatectomy: Validation study from 3 centers.
Cancer
; 125(3): 391-397, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30423193
7.
Does time from diagnosis to treatment of high- or very-high-risk prostate cancer affect outcome?
BJU Int
; 124(2): 282-289, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30653804
10.
Risk of Pathological Upgrading and Up Staging among Men with Low Risk Prostate Cancer Varies by Race: Results from the National Cancer Database.
J Urol
; 197(3 Pt 1): 627-631, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27582435
11.
Establishment of a new prostate cancer multidisciplinary clinic: Format and initial experience.
Prostate
; 75(2): 191-9, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25307625
12.
Identification of men with the highest risk of early disease recurrence after radical prostatectomy.
Prostate
; 74(6): 628-36, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24453066
13.
14.
Pathological examination of radical prostatectomy specimens in men with very low risk disease at biopsy reveals distinct zonal distribution of cancer in black American men.
J Urol
; 191(1): 60-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23770146
15.
Outcomes of men with an elevated prostate-specific antigen (PSA) level as their sole preoperative intermediate- or high-risk feature.
BJU Int
; 114(6b): E120-E129, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24731026
16.
Melanoma Antigen Family A (MAGE A) as Promising Biomarkers and Therapeutic Targets in Bladder Cancer.
Cancers (Basel)
; 16(2)2024 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254738
17.
A Comprehensive Review of Immunotherapy Clinical Trials for Metastatic Urothelial Carcinoma: Immune Checkpoint Inhibitors Alone or in Combination, Novel Antibodies, Cellular Therapies, and Vaccines.
Cancers (Basel)
; 16(2)2024 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254823
18.
Roles of Androgen Receptor Signaling in Urothelial Carcinoma.
Cancers (Basel)
; 16(4)2024 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38398136
19.
Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions.
Nat Genet
; 56(5): 809-818, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38671320
20.
Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients' access to novel therapeutics.
Urol Oncol
; 41(9): 390.e1-390.e17, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37061453